Biotech News

Sotera Health Reports Solid Third-Quarter and Year-to-Date 2026 Results

Sotera Health (SHC)Sotera HealthEarnings

Q3 2026 net revenues increased 4.4% on both an as-reported and constant currency basis (1), compared to Q3 2025 Q3 2026 net income of $58 million or $0.20 per diluted share Q3 2026 Adjusted EBITDA ( 1) increased 3.9%, or 4.0% on a constant currency basis Q3 2026 Adjusted EPS (1) of $0.29, an

Related news

Sotera Health

Healthcare Sterilization Infrastructure Sotera Health provides sterilization, laboratory testing and advisory services that support the safety and regulatory compliance of medical devices, pharmaceuticals and other healthcare products. Its businesses operate at critical points between product manufacturing and release to...

Recent company news

Stock data

Close
15.87 USD
Market cap
4.28B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States